Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CRNX

Crinetics Pharmaceuticals Inc

Nov 28 • 02:07PM ET

31.37

Dollar change -0.44
Percentage change -1.38	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.64	Insider Own	14.79%	Shs Outstand	66.80M	Perf Week	3.81%
Market Cap	2.10B	Forward P/E	-	EPS next Y	-3.44	Insider Trans	-3.35%	Shs Float	56.92M	Perf Month	10.77%
Income	-199.42M	PEG	-	EPS next Q	-0.86	Inst Own	91.93%	Short Float / Ratio	10.90% / 3.94	Perf Quarter	89.89%
Sales	0.71M	P/S	2951.43	EPS this Y	-14.79%	Inst Trans	1.59%	Short Interest	6.20M	Perf Half Y	42.27%
Book/sh	8.21	P/B	3.82	EPS next Y	4.77%	ROA	-38.86%	Target Price	46.82	Perf Year	73.41%
Cash/sh	8.30	P/C	3.78	EPS next 5Y	-	ROE	-44.36%	52W Range	15.23 - 32.87	Perf YTD	71.42%
Dividend	-	P/FCF	-	EPS past 5Y	-52.45%	ROI	-33.46%	52W High	-4.56%	Beta	0.56
Dividend %	-	Quick Ratio	14.23	Sales past 5Y	67.89%	Gross Margin	-105.50%	52W Low	105.98%	ATR	1.59
Employees	210	Current Ratio	14.23	Sales Q/Q	-	Oper. Margin	-29833.43%	RSI (14)	60.41	Volatility	4.83% 5.83%
Optionable	Yes	Debt/Eq	0.10	EPS Q/Q	-29.72%	Profit Margin	-28127.36%	Rel Volume	0.15	Prev Close	31.81
Shortable	Yes	LT Debt/Eq	0.09	Earnings	Nov 07 AMC	Payout	-	Avg Volume	1.57M	Price	31.37
Recom	1.09	SMA20	6.58%	SMA50	9.17%	SMA200	45.41%	Volume	176,087	Change	-1.38%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-20-23	Resumed	JP Morgan	Overweight	$35
Oct-24-23	Resumed	Cantor Fitzgerald	Overweight	$52 → $50
Aug-31-23	Initiated	Oppenheimer	Outperform	$40
Apr-24-23	Initiated	Piper Sandler	Overweight	$56
Mar-30-23	Initiated	Robert W. Baird	Outperform	$48
Nov-30-21	Initiated	JMP Securities	Mkt Outperform	$43
Nov-23-21	Initiated	Evercore ISI	Outperform	$68
Jun-18-21	Upgrade	JP Morgan	Neutral → Overweight	$28
Dec-23-19	Initiated	ROTH Capital	Buy	$37
Feb-14-19	Initiated	H.C. Wainwright	Buy	$35
Aug-13-18	Initiated	Piper Jaffray	Overweight	$40
Aug-13-18	Initiated	Leerink Partners	Outperform	$43
Aug-13-18	Initiated	JP Morgan	Neutral	$29

Show Previous Ratings

Nov-20-23 04:05PM	Crinetics Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-17-23 08:39AM	Billionaire Steve Cohen Goes Big on These 2 Strong Buy Stocks Heres Why You Should Follow (TipRanks) +5.82%
Nov-10-23 05:00PM	Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-09-23 05:45AM	Crinetics Pharmaceuticals Inc (CRNX) Reports Q3 2023 Results: Phase 3 Success and Financial Growth (GuruFocus.com) -6.19%
Nov-08-23 09:55AM	Wall Street Analysts See a 56.94% Upside in Crinetics Pharmaceuticals, Inc. (CRNX): Can the Stock Really Move This High? (Zacks)
08:50AM	Loading…
08:50AM	Here's What Could Help Crinetics Pharmaceuticals, Inc. (CRNX) Maintain Its Recent Price Strength (Zacks)
Nov-07-23 04:05PM	Crinetics Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-04-23 05:03AM	Insider Sell: CFO Marc Wilson Sells 10,000 Shares of Crinetics Pharmaceuticals Inc (CRNX) (GuruFocus.com)
Oct-23-23 09:55AM	Wall Street Analysts Think Crinetics Pharmaceuticals, Inc. (CRNX) Could Surge 55.53%: Read This Before Placing a Bet (Zacks)
08:50AM	What Makes Crinetics Pharmaceuticals, Inc. (CRNX) a Good Fit for 'Trend Investing' (Zacks)
Oct-20-23 01:02AM	Insider Sell: Chief Medical Officer Alan Krasner Sells 7,000 Shares of Crinetics Pharmaceuticals Inc (GuruFocus.com) +5.92%
Oct-11-23 09:00AM	Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment (PR Newswire)
Oct-10-23 05:00PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-03-23 07:00AM	7 Speculative Stocks Set to Explode Higher (InvestorPlace)
Sep-28-23 11:18AM	Crinetics (CRNX) Stock Surges 70% in a Month: Here's Why (Zacks)
08:00AM	Loading…
Sep-20-23 08:00AM	Crinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023 (GlobeNewswire)
Sep-15-23 08:37AM	Why Crinetics Pharmaceuticals Stock Soared This Week (Motley Fool)
Sep-12-23 10:26PM	Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock (GlobeNewswire) +17.29%
Sep-11-23 04:04PM	Crinetics Pharmaceuticals Just Scored A Much-Needed Win And Soared 63% (Investor's Business Daily) +63.31%
04:01PM	Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock (GlobeNewswire)
12:57PM	Why Shares of Crinetics Pharmaceuticals Are Jumping Monday (Motley Fool)
06:00AM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
05:43AM	Crinetics shares surge after "positive" hormonal disorder drug trial results (Investing.com)
Sep-10-23 10:00AM	Crinetics Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-1 Study Evaluating Treatment of Patients with Acromegaly (GlobeNewswire)
Sep-05-23 08:55PM	Oppenheimer Says These 2 Stocks Could Double Your Money Heres Why They Could Jump (TipRanks)
Aug-13-23 09:02AM	Will Crinetics Pharmaceuticals (NASDAQ:CRNX) Spend Its Cash Wisely? (Simply Wall St.)
Aug-10-23 05:34PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-08-23 07:00AM	Crinetics Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-31-23 08:01AM	Crinetics Hosting Key Opinion Leader Webinar to Discuss the Current Treatment Landscape and Unmet Need in Acromegaly (GlobeNewswire)
Jul-10-23 04:18PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.73%
07:59AM	Loading…
Jun-21-23 07:59AM	New Data Demonstrating Stable Biochemical and Symptom Levels with Two-Years of Oral Paltusotine Administration Presented at ENDO 2023 (GlobeNewswire)
Jun-12-23 07:30AM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-09-23 07:30AM	Crinetics to Highlight Broad Pipeline at ENDO 2023 (GlobeNewswire)
May-10-23 04:21PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-06-23 08:07AM	Crinetics Pharmaceuticals First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
May-04-23 07:35PM	Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Crinetics Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
10:00AM	Earnings Preview: Crinetics Pharmaceuticals, Inc. (CRNX) Q1 Earnings Expected to Decline (Zacks)
Apr-16-23 09:34AM	The past year for Crinetics Pharmaceuticals (NASDAQ:CRNX) investors has not been profitable (Simply Wall St.)
Apr-10-23 04:31PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-28-23 03:57PM	Top 10 Growth Stocks in Biotech (Insider Monkey)
Mar-10-23 04:37PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.05%
Mar-06-23 07:05AM	We Think Crinetics Pharmaceuticals (NASDAQ:CRNX) Can Afford To Drive Business Growth (Simply Wall St.)
Feb-28-23 05:25PM	Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-10-23 05:21PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:01AM	Crinetics Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-10-23 04:48PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-09-23 08:01AM	Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.59%
Dec-12-22 04:01PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-28-22 08:00AM	Crinetics Pharmaceuticals Provides Update on CRN04777 Program (GlobeNewswire) -5.86%
Nov-22-22 08:00AM	Crinetics Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference (GlobeNewswire)
Nov-14-22 09:15AM	Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
08:00AM	Crinetics Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-10-22 04:30PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +10.52%
Nov-06-22 07:26AM	Shareholders in Crinetics Pharmaceuticals (NASDAQ:CRNX) are in the red if they invested a year ago (Simply Wall St.)
Oct-13-22 08:00AM	Enrollment Completed in Phase 3 PATHFNDR-1 Study Evaluating Oral Paltusotine for the Treatment of Acromegaly (GlobeNewswire)
Oct-10-22 04:57PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-06-22 08:00AM	Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism (GlobeNewswire)
Oct-03-22 08:00AM	Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer (GlobeNewswire)
Sep-26-22 10:29AM	We're Not Very Worried About Crinetics Pharmaceuticals' (NASDAQ:CRNX) Cash Burn Rate (Simply Wall St.)
Sep-12-22 08:00AM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-08-22 08:00AM	Crinetics Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Sep-06-22 08:00AM	New Long-Term Safety and Efficacy Data Presented with Paltusotine in Participants Living with Acromegaly (GlobeNewswire)
Sep-02-22 08:00AM	New Long-Term Safety and Efficacy Data for Investigational Compound Paltusotine to be Presented at the Brazilian Congress of Endocrinology and Metabolism (GlobeNewswire)
Aug-12-22 09:15AM	Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
08:00AM	Crinetics Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-10-22 04:44PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-04-22 08:00AM	Additional Analyses of CRN04894 Preclinical and Phase 1 Results to be Presented at the 10th International Congress of Neuroendocrinology (GlobeNewswire) +5.53%
Jul-12-22 05:09PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-04-22 10:57AM	How Much Of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Do Institutions Own? (Simply Wall St.)
Jun-10-22 04:30PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-08-22 07:30AM	Crinetics Presents Clinical and Research Results at ENDO 2022 (GlobeNewswire)
Jun-07-22 07:30AM	Crinetics Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference (GlobeNewswire) +8.72%
May-25-22 07:00AM	Crinetics Pharmaceuticals Reports Positive Top-line Results Including Strong Adrenal Suppression from CRN04894 Phase 1 Study Multiple-Ascending Dose Cohorts (GlobeNewswire) -11.65%
May-19-22 09:56AM	Strong week for Crinetics Pharmaceuticals (NASDAQ:CRNX) shareholders doesn't alleviate pain of three-year loss (Simply Wall St.)
May-12-22 04:42PM	Crinetics Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire) +5.04%
May-10-22 04:18PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +6.73%
Apr-28-22 11:13AM	Molina Healthcare (MOH) Q1 Earnings Beat on Higher Premiums (Zacks)
Apr-27-22 04:34PM	Humana (HUM) Q1 Earnings Beat on Solid Healthcare Services (Zacks)
Apr-19-22 09:47AM	We're Hopeful That Crinetics Pharmaceuticals (NASDAQ:CRNX) Will Use Its Cash Wisely (Simply Wall St.)
Apr-18-22 04:01PM	Crinetics Pharmaceuticals Announces Closing of Underwritten Common Stock Offering (GlobeNewswire) -11.77%
Apr-12-22 11:50PM	Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering (GlobeNewswire)
Mar-30-22 04:02PM	Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire)
04:01PM	Crinetics Pharmaceuticals Reports Positive Top-Line Results from CRN04777 Phase 1 Study Multiple-Ascending Dose Cohorts (GlobeNewswire)
Mar-21-22 07:30AM	Crinetics Pharmaceuticals Appoints Chris Robillard as Chief Business Officer (GlobeNewswire)
Mar-14-22 07:30AM	Crinetics Pharmaceuticals Appoints Caren Deardorf to Board of Directors (GlobeNewswire)
Mar-10-22 05:20PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-01-22 08:00AM	Crinetics Pharmaceuticals Expands Executive Team with Appointment of James Hassard as Chief Commercial Officer (GlobeNewswire)
Feb-28-22 06:00AM	Crinetics Pharmaceuticals and Sanwa Kagaku Kenkyusho Enter into Exclusive Licensing Agreement for the Development and Commercialization of Paltusotine in Japan (GlobeNewswire)
Feb-09-22 07:30AM	Crinetics Pharmaceuticals to Participate in SVB Leerink Global Healthcare Conference (GlobeNewswire)
Feb-01-22 04:42PM	Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-24-22 04:38AM	What Kind Of Investors Own Most Of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)? (Simply Wall St.)
Jan-12-22 07:30AM	Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 40th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-28-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-21-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-16-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-08-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Nov-18-21 08:00AM	Crinetics Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference (GlobeNewswire)
Nov-17-21 10:23AM	Does Crinetics Pharmaceuticals, Inc. (CRNX) Have the Potential to Rally 35% as Wall Street Analysts Expect? (Zacks)

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Struthers Richard Scott	President & CEO	Nov 09	Option Exercise	1.91	50,000	95,500	185,522	Nov 13 04:33 PM
Struthers Richard Scott	President & CEO	Nov 03	Option Exercise	9.28	199,082	1,847,481	334,604	Nov 06 06:02 PM
Struthers Richard Scott	President & CEO	Nov 03	Sale	30.56	199,082	6,083,946	135,522	Nov 06 06:02 PM
Struthers Richard Scott	President & CEO	Nov 02	Option Exercise	9.28	918	8,519	136,440	Nov 06 06:02 PM
Struthers Richard Scott	President & CEO	Nov 02	Sale	29.95	918	27,494	135,522	Nov 06 06:02 PM
Wilson Marc	CFO	Nov 01	Option Exercise	9.28	10,000	92,800	105,601	Nov 03 07:38 PM
Wilson Marc	CFO	Nov 01	Sale	28.75	10,000	287,500	95,601	Nov 03 07:38 PM
Krasner Alan Seth	Chief Medical Officer	Oct 17	Option Exercise	12.01	7,000	84,070	50,210	Oct 19 05:01 PM
Krasner Alan Seth	Chief Medical Officer	Oct 17	Sale	30.00	7,000	210,000	43,210	Oct 19 05:01 PM
Struthers Richard Scott	President & CEO	Aug 14	Option Exercise	1.91	10,000	19,100	135,522	Aug 16 04:30 PM
Struthers Richard Scott	President & CEO	Jul 13	Sale	20.35	14,157	288,095	630,805	Jul 13 04:56 PM
Struthers Richard Scott	President & CEO	Jul 12	Sale	20.17	11,459	231,128	644,962	Jul 13 04:56 PM
Struthers Richard Scott	President & CEO	Jul 11	Sale	20.14	24,384	491,094	656,421	Jul 13 04:56 PM
Wilson Marc	CFO	Jun 20	Option Exercise	9.28	20,000	185,600	115,158	Jun 21 05:32 PM
Wilson Marc	CFO	Jun 20	Sale	19.97	30,922	617,403	95,158	Jun 21 05:32 PM
Struthers Richard Scott	President & CEO	Jun 16	Sale	20.81	50,000	1,040,500	680,805	Jun 21 05:27 PM
Vivaldi Coelho Rogerio	Director	Jun 08	Buy	22.06	5,000	110,300	5,000	Jun 09 08:00 AM
Pizzuti Dana	Chief Development Officer	Apr 05	Sale	16.15	8,212	132,624	4,500	Apr 05 07:12 PM
Betz Stephen F.	Chief Scientific Officer	Feb 01	Sale	19.59	3,126	61,238	64,689	Feb 03 04:30 PM
Betz Stephen F.	Chief Scientific Officer	Jan 25	Sale	21.07	8,336	175,640	67,815	Jan 27 04:26 PM
Betz Stephen F.	Chief Scientific Officer	Jan 17	Sale	18.00	3,126	56,268	76,151	Jan 19 04:28 PM
Betz Stephen F.	Chief Scientific Officer	Jan 03	Sale	18.35	3,126	57,362	79,277	Jan 05 04:23 PM
Betz Stephen F.	Chief Scientific Officer	Dec 15	Sale	16.00	3,126	50,016	82,403	Dec 19 05:11 PM
Betz Stephen F.	Chief Scientific Officer	Dec 01	Sale	17.84	3,126	55,768	84,968	Dec 05 05:28 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CRNX

Crinetics Pharmaceuticals Inc

Upgrade your FINVIZ experience